Diabetic ketoacidosis and surgical procedures


alert shortage warning
The TGA has issued a safety advisory regarding odium glucose co-transporter 2 inhibitors The TGA says it is working with sponsors of sodium glucose co-transporter 2 (SGLT2) inhibitors to update medicine information documents to strengthen warnings about the risk of diabetic ketoacidosis with these medicines. “In particular, the risk is increased in people who undergo

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A nudge in the right direction
Next Is your pharmacy safe from a cyber-attack?